Paradigm Biocapital Advisors’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$36.5M Hold
1,553,748
– – 0.73% 22
2026
Q2
$42.7M Buy
1,553,748
+888,497
+134% +$24.2M 0.8% 20
2026
Q1
$18.5M Hold
665,251
– – 0.38% 33
2025
Q4
$22.6M Buy
+665,251
New +$21.4M 0.58% 27

Other funds holding ASMB

Paradigm Biocapital Advisors's ASMB Position: Q3 2026 in Review

Paradigm Biocapital Advisors held its Assembly Biosciences (ASMB) position steady in Q3 2026 at 1,553,748 shares worth $36.5M. The position accounts for 0.73% of the portfolio, ranked #22.

Paradigm Biocapital Advisors first reported a position in ASMB in Q4 2025 and has held it in 4 quarters since. The position peaked at $42.7M in Q2 2026. 104 funds tracked by Wall St. Rank hold ASMB as of Q3 2026.

  • Paradigm Biocapital Advisors held 1,553,748 shares of Assembly Biosciences worth $36.5M as of Q3 2026.
  • Paradigm Biocapital Advisors left its Assembly Biosciences share count unchanged in Q3 2026.
  • Assembly Biosciences made up 0.73% of Paradigm Biocapital Advisors's portfolio in Q3 2026, its #22 holding.
  • Paradigm Biocapital Advisors first reported a position in Assembly Biosciences in Q4 2025 and has held it in 4 quarters since.
  • Paradigm Biocapital Advisors's Assembly Biosciences position peaked at $42.7M in Q2 2026.
  • 104 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2026.

Based on Paradigm Biocapital Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.